Hydroxychloroquine is first-line at Yale because in-vitro data shows potent inhibition of the virus and possible clinical benefit, which is about as good as evidence gets at the moment, Indian American cardiologist Nihar Desai told the medical publication.
from Top World News- News18.com https://ift.tt/3aSGBtf
Subscribe to:
Post Comments (Atom)
-
The Doha accord would see thousands of American troops quit Afghanistan in a phased plan after more than 18 years in return for various secu...
-
A mysterious dissident group accused of breaking into the North Korea's embassy in Madrid last month said on Thursday it was temporarily...
-
The launch on Monday came two days North Korea's state media said leader Kim Jong Un supervised an artillery drill aimed at testing the ...
No comments:
Post a Comment